Cajulis R S, Szumel R, Frias-Hidvegi D, Combs S G, Radosevich J A
Department of Pathology, Northwestern University/VA Lakeside Medical Center, Chicago, IL.
Diagn Cytopathol. 1993;9(2):179-83. doi: 10.1002/dc.2840090214.
Monoclonal antibody (MCA) 44-3A6 detects a cell-surface transmembrane phosphoprotein frequently expressed by pulmonary adenocarcinoma (AC) and associated with glandular differentiation. This antibody has been found to have utility in assessing routine formalin fixed paraffin-embedded pulmonary neoplasms, as well as the cytopathological evaluation of sputum and bronchial brushings. Recently, it has been shown to be useful in cytological diagnosis of pleural effusions. This study is directed at evaluating its effectiveness in detecting immunoreactive neoplastic cells in body fluids (BF) arising in other tissues. A retrospective cohort of 57 cases was studied, consisting of 36 pleural, 19 ascitic, and 2 pericardial BF. After evaluation of Papanicolaou-stained slides, the BF specimens were immunostained with MCA 44-3A6 using the avidin-biotin-peroxidase complex (ABC) method. In 29 cases, tissue sections of the primary tumors, were also available for immunostaining with MCA 44-3A6. Results showed that 39/42 (93%) of AC BF cases were positive and 28/42 (66%) stained intensely (3-4+) with 75-100% of the AC cells staining in each case. All of the 18 benign and non-AC malignant BF were negative. The staining patterns in the tissue sections of the 29 cases that had corresponding BF samples were similar. We conclude from this study that the MCA 44-3A6 (1) is useful in detecting cells consistent with AC in BF; (2) does not stain inflammatory cells or reactive mesothelial cells, thus helping distinguish reactive from malignant BF; and (3) frequency and pattern of expression in BF parallels its expression in tissue specimens. This study confirms that this MCA is a useful adjunct tool in the cytopathological evaluation of BF.
单克隆抗体(MCA)44 - 3A6可检测一种细胞表面跨膜磷蛋白,该蛋白在肺腺癌(AC)中频繁表达且与腺分化相关。已发现该抗体可用于评估常规福尔马林固定石蜡包埋的肺部肿瘤,以及痰液和支气管刷片的细胞病理学评估。最近,它在胸腔积液的细胞学诊断中也显示出有用性。本研究旨在评估其在检测其他组织来源的体液(BF)中免疫反应性肿瘤细胞方面的有效性。对57例病例进行了回顾性队列研究,包括36例胸腔、19例腹水和2例心包BF。在评估巴氏染色玻片后,使用抗生物素蛋白 - 生物素 - 过氧化物酶复合物(ABC)方法用MCA 44 - 3A6对BF标本进行免疫染色。在29例病例中,原发性肿瘤的组织切片也可用于用MCA 44 - 3A6进行免疫染色。结果显示,42例AC BF病例中有39例(93%)呈阳性,28例(66%)染色强烈(3 - 4 +),每例中75 - 100%的AC细胞染色。18例良性和非AC恶性BF均为阴性。29例有相应BF样本的病例的组织切片中的染色模式相似。我们从本研究得出结论,MCA 44 - 3A6(1)可用于检测BF中与AC一致的细胞;(2)不染色炎症细胞或反应性间皮细胞,从而有助于区分反应性与恶性BF;(3)在BF中的表达频率和模式与其在组织标本中的表达平行。本研究证实该MCA是BF细胞病理学评估中一种有用的辅助工具。